Health Boards
›
Psoriasis In The News
Germany says Cosentyx shows no added benefit for psoriatic arthritis.
|
Germany says Cosentyx shows no added benefit for psoriatic arthritis.
|
Wed-23-03-2016, 23:15 PM
Politics as usual. The manufacturer doesn't need to spend millions USD to figure out where consentyx stands with PsA. It's no better than the TNfs if you consider the current standard. However, there isn't a drug that has statistically shown superiority over TNFs. What we do know is the TNFs have a high rate of failure or reduced benefit over a prolonged period of time. It's nice to give another option for those people.
|
|
« Next Oldest | Next Newest »
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
Bimzelx vs Skyrizi study for psoriatic arthritis | Fred | 0 | 511 |
Mon-30-09-2024, 14:22 PM Last Post: Fred |
|
|
Polymorphisms associated with Cosentyx | Fred | 6 | 2,950 |
Sun-07-01-2024, 11:01 AM Last Post: Caroline |
|
|
Bimzelx gets recommendation for psoriatic arthritis in the EU | Fred | 2 | 2,649 |
Sat-10-06-2023, 14:33 PM Last Post: Forest Walker |
|
|
Tremfya for psoriatic arthritis phase 3b data | Fred | 0 | 1,485 |
Wed-31-05-2023, 16:26 PM Last Post: Fred |
|
|
Bimzelx and psoriatic arthritis long term data | Fred | 0 | 1,572 |
Wed-31-05-2023, 14:00 PM Last Post: Fred |
